Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tbf Genie Tissulaire (Tbf) holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action in the portfolio. This action is assigned to 1 distinct examiner and 1 distinct art unit, indicating a concentrated prosecution focus.
The busiest examiner for the company is BOECKELMAN, JACOB A, who is responsible for 1 pending office action. With only 1 pending office action total, this examiner manages the full scope of the company's current pending matters. The focus on 1 distinct art unit indicates that the company's current biotechnology prosecution is concentrated in a single specialized area of the patent office. For a practitioner, this means the success of the company's current biotechnology filings depends entirely on the outcome of this single office action with BOECKELMAN, JACOB A. The presence of 1 distinct examiner for the only pending action in the portfolio highlights a singular point of focus for the company's current biotechnology prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18575571 | BIOLOGICAL MATERIAL IMPREGNATED WITH A SOLUTION COMPRISING EXOSOMES | BOECKELMAN, JACOB A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18575571 | BIOLOGICAL MATERIAL IMPREGNATED WITH A SOLUTION COMPRISING EXOSOMES | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18575571 | BIOLOGICAL MATERIAL IMPREGNATED WITH A SOLUTION COMPRISING EXOSOMES | BOECKELMAN, JACOB A | 1655 | §101§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTbf Genie Tissulaire (Tbf) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacob A Boeckelman has the most, with 1 of Tbf Genie Tissulaire (Tbf)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
